Sun Pharma has recalled 12 eye‑drop products across India due to possible contamination, halting distribution and urging patients to consult their ophthalmologists before making any changes to treatment.
Key Takeaways
- Sun Pharma recalls several eye‑drop products
- All stock must be returned and distribution stopped
- Patients advised to contact eye doctors immediately
New Delhi, August 3, 2026 – Pharmaceutical giant Sun Pharma announced a nationwide recall of twelve eye‑drop products after contamination concerns surfaced during manufacturing. A confidential letter to distributors instructed an immediate market withdrawal and return of all existing inventory.
The recalled items include Depopred 2 ml, Brinolar (BKC‑Free), Brinzotim Eye Drops 5 ml BKC‑Free, Lotepred‑5 ml, Lotepred 1% Eye Drops, Lotepred LS 0.2%, Lotepred T, Nepalact OD 3 ml, Nepalact‑Z, Toba‑F, and Nepalact 5 ml. Distributors were told to stop billing these products, report any remaining stock, and prioritize the return of units received from any source.
A Sun Pharma spokesperson told ANI, “Patient safety remains our highest priority. We have taken all steps required by regulators and are working to restore product availability as quickly as possible.”
Why This Matters
BozokMedia analysis shows that such recalls, although precautionary, highlight the critical importance of strict sterility standards in ophthalmic manufacturing. Any lapse can jeopardize vision‑critical treatments and erode public trust in pharma brands.
Dr. Anil Kumar, ophthalmologist: “Sterility in eye‑drop production must never be compromised, as these medicines are applied directly to the eye.”
Frequently Asked Questions
- Question: What should I do if I have been using a recalled eye drop?
Answer: Stop using it immediately and contact your ophthalmologist for a safe alternative. - Question: How long does a recall process usually take?
Answer: Typically, distributors retrieve stock within 2‑3 business days, but final clearance can take several weeks.
